US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 78.710
  • +0.650+0.83%
Close Jul 19 16:00 ET
  • 79.510
  • +0.800+1.02%
Pre 08:01 ET
244.04BMarket Cap38.87P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 25, 2024

Revenue(YoY)

12.56B

+9.98%
EPS(YoY)

0.76

+30.74%
Analyst Rating

Strong Buy

Jul 21, 2024

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 12, 20242024/Q3-- / 12.966B--
Jul 25, 20242024/Q2-- / 12.556B--
Apr 25, 20242024/Q112.679B / 11.812B--
--2023/Q412.024B / 12.007B--
Nov 9, 20232023/Q311.492B / 11.529B--
DatePeriodRevenue/EstimateEarnings Call
Nov 12, 20242024/Q3-- / 12.966B--
Jul 25, 20242024/Q2-- / 12.556B--
Apr 25, 20242024/Q112.679B / 11.812B--
--2023/Q412.024B / 12.007B--
Nov 9, 20232023/Q311.492B / 11.529B--

Unlock Free Earnings Estimates

AstraZeneca Earnings Reports

  • AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

    May 21 06:10 ET

  • 6-K: Q1 2024 Results

    Apr 25 06:29 ET

  • AstraZeneca | 6-K: Closure of Notes Sale Pursuant to Underwriting Agreement

    Feb 26 16:10 ET

  • AstraZeneca | 20-F: Registration statement / Annual report / Transition report

    Feb 20 22:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg